The recent clue that LSD1 inhibition might indirectly modify T cell and immunotherapy responses through upregulation of chemokines and their receptors to enhance CD8+ T cell tumor infiltration prompted us to look more closely at this phenomenon (6, 22). Here, KDM1A is linked to neoplasm.